Stock Comparison
ARGX vs ROIV
argenx NV ADR and Roivant Sciences Ltd side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$26.62B
P/E (TTM)
32.7
—
Forward P/E
30.4
—
Price/Sales
10.0
3,533.7
Price/Book
6.4
6.3
EV/EBITDA
27.6
0.8
Dividend Yield
—
—
Profitability
Net Margin
30.44%
-3629.19%
Operating Margin
27.34%
-15560.57%
Return on Equity
23.60%
-8.52%
Return on Assets
11.60%
-16.50%
Growth (YoY)
Revenue Growth
59.30%
-33.50%
Earnings Growth
95.20%
-96.10%
Price & Risk
Beta
-0.0
1.1
52-Week High
$939.68
$36.81
52-Week Low
$652.43
$11.64
Analyst Target
$1,085.78
$38.91
Compare ARGX and ROIV your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.